Press release
Quince Therapeutics Reports Favorable iDSMB Safety Review for eDSP in Ongoing Phase 3 NEAT Trial for Ataxia Telangiectasia
The trial named NEAT (Neurological Effects of eDSP in Subjects with Ataxia Telangiectasia; NCT06193200/IEDAT 04 2022) is an international, multicenter, randomized, double blind, placebo controlled study evaluating eDSP in Ataxia Telangiectasia patients. The therapy uses Quince's proprietary Autologous Intracellular Drug Encapsulation (AIDE) platform to encapsulate dexamethasone sodium phosphate in a patient's own red blood cells, aiming to deliver corticosteroid efficacy while reducing the side effect burden of chronic steroid use.
According to the company, the safety review reaffirms confidence in the favourable safety profile of eDSP to date. The CEO/CMO Dirk Thye, M.D. noted the company remains on track to report topline results in the first quarter of 2026.
With no modifications recommended by the iDSMB, Quince can continue the Phase 3 NEAT trial as designed, providing a clearer path forward toward a potential first to market treatment for A T, a rare and serious neurological disease with significant unmet need. The positive review may support investor confidence, regulatory dialogue, and future commercial strategy.
Unlock comprehensive insights on Ataxia Telangiectasia, explore market trends, epidemiology, and forecasts through 2034 to drive strategic decisions.
https://www.delveinsight.com/report-store/ataxia-telangiectasia-at-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
How a DelveInsight Report Helps in Keen Market Research
DelveInsight offers comprehensive, indication and therapy area specific reports that include epidemiology, market size, forecasting, pipeline analysis, and competitive landscapes. For a condition such as Ataxia Telangiectasia, a DelveInsight report would provide:
• Historical and forecasted incidence/prevalence of Ataxia Telangiectasia across key geographies
• Key drivers of market growth and unmet needs in the disease area
• A detailed view of the clinical pipeline (including eDSP and competing therapies)
• Market opportunity sizing and segmentation (by geography, patient sub type, treatment stage)
• Competitive landscape and possible regulatory / reimbursement scenarios
By combining the clinical milestone from Quince with DelveInsight's structured market intelligence, stakeholders can evaluate how this trial result might influence market entry timelines, commercial potential, patient pool size, and revenue projections. In short, the DelveInsight report acts as a strategic tool to translate clinical developments into business insights and planning.
Discover actionable intelligence on Ataxia Telangiectasia market size, trends, and long-term forecasts through 2034 for informed planning.
https://www.delveinsight.com/sample-request/ataxia-telangiectasia-at-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Quince Therapeutics Reports Favorable iDSMB Safety Review for eDSP in Ongoing Phase 3 NEAT Trial for Ataxia Telangiectasia here
News-ID: 4264763 • Views: …
More Releases from DelveInsight Business Research
Limbal Stem Cell Deficiency Market to Surpass USD 2.6 Billion by 2034, Driven by …
In 2023, the Limbal Stem Cell Deficiency (LSCD) market was dominated by the United States, generating nearly USD 1.5 billion in revenue, while Spain represented the smallest market with approximately USD 127 million. This regional distribution is expected to remain consistent throughout the forecast timeline. The US accounted for nearly 103,000 diagnosed LSCD cases, whereas Japan recorded around 37,000 cases, with both countries projected to witness notable growth in patient…
SSc-ILD Market Set to Cross USD 750 Million by 2034, Driven by 10+ Emerging Ther …
The major players operating in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market include Roche, Prometheus Biosciences, Inc., Merck, GlaxoSmithKline, Genentech, Inc., Acceleron, Boehringer Ingelheim, Actelion, Hôpital Claude-Huriez, Changchun GeneScience Pharmaceutical, among others.
DelveInsight's report titled "Systemic Sclerosis-associated Interstitial Lung Disease Market Insights, Epidemiology, and Forecast-2034" delivers a comprehensive analysis of SSc-ILD, covering historical data, projected epidemiology, and evolving market trends across the United States, EU4 (Germany, Spain, Italy, and France),…
Developmental and Epileptic Encephalopathy Treatment Market Poised for Accelerat …
The Developmental and Epileptic Encephalopathy (DEE) treatment market across the seven major markets (7MM) was valued at nearly USD 2.1 billion in 2023 and is expected to register a healthy compound annual growth rate over the forecast period. The United States emerged as the largest contributor, capturing close to 80% of the overall market revenue.
The DEE treatment landscape is undergoing a significant transformation as the limitations of traditional antiepileptic drugs…
Polycythemia Vera Pipeline and Drug Development in 2025: 10+ Therapies and 8+ Co …
DelveInsight's "Polycythemia Vera Pipeline Insight 2025" report delivers an in-depth overview of the Polycythemia Vera pipeline landscape, covering more than 8 companies and 10+ pipeline candidates. The report analyzes both clinical-stage and preclinical assets, offering detailed drug profiles across various stages of development. It also evaluates Polycythemia Vera therapies based on product classification, development stage, route of administration, and molecular category, while additionally spotlighting inactive or discontinued pipeline assets.
Explore the…
More Releases for Quince
Baby Food Market -Exclusive Report by Quince Market Insights | Hero Group, Bella …
Baby Food Market Overview:
The Baby Food market is projected to grow by USD by 2023 rapidly at a CAGR throughout the forecast period 2023-2032
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
Factors like increase in funding for Baby Food research…
EV Traction Motor Market to Perceive Biggest Trend and Trending Opportunity by 2 …
The EV Traction Motor Market research report provides in-depth information on market trends, market capacity, industry size, growth factors, share, innovations, competitive environment, business problems, and more. This report's historical data confirms demand growth on a global, national, and regional scale. The studies on the global industry cover everything from comprehensive research to market size and forecasting to dynamics, growth factors, prospects, and hazards, as well as vendor knowledge. The…
Workflow Orchestration Market Size, Share, Trends and industry analysis now avai …
Scope of the Global Workflow Orchestration Market
This detailed market analysis study gives a quantitative perspective of the global Workflow Orchestration Market , combining main considerations such as the full scale of the global market, country, and regional market share, as well as market revenue values. This study also provides a summary of current developments and lucrative prospects, competitive environment and sales research, planned product releases, revenue, and industry. This research…
Canola Seed Market Size, Share, Trends and industry analysis now available from …
Scope of the Global Canola Seed Market
This detailed market analysis study gives a quantitative perspective of the global Canola Seed Market , combining main considerations such as the full scale of the global market, country, and regional market share, as well as market revenue values. This study also provides a summary of current developments and lucrative prospects, competitive environment and sales research, planned product releases, revenue, and industry. This research…
2-Nitrochlorobenzene Market Production Analysis and Geographical Market Performa …
The 2-Nitrochlorobenzene market is growing at a rapid pace in terms of revenue, growth rate, sales, market share, and size, contributing significantly to the global economy. The 2-Nitrochlorobenzene Market Report is a comprehensive research paper that provides readers with valuable information to understand the fundamentals of the 2-Nitrochlorobenzene Report. The study describes business strategies, customer desires, dominant market players, and a futuristic view of the market.
Sample Copy of This Report:…
Global Geospatial Analytics Market Analysis, Company Profile, Future Estimations …
"The global Geospatial Analytics market research report provides in-depth information on every leading market supplier. Apart from this, it also provides a detailed study of both demands as well as supply chain in the end-use segment. The study also offers positive as well as negative results on the basis of the targeted customer demand. The report is also being presented by conducting a detailed analysis of the global market dynamics…
